iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed May 20, 2013 · 10-Q · 50 days after period end · 0000930413-13-003036
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $0.00 | $371.76K | $176.00K |
| Net Income | -$1.76M | -$3.10M | -$3.03M |
| EPS Diluted | -$0.04 | -$0.07 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 20, 2013 · 50 d after period end
